VRTX34:BVMF
Vertex Pharmaceuticals Inc BDR
R$80.08
0.00%
(0.00) 1D
Oct 9, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX34...
Open
R$80.08
High
R$80.08
Low
R$80.08
Mkt. cap
128.50B
Avg. vol.
374.00
Volume
1.00
52-wk high
R$89.01
52-wk low
R$65.18
Shares outstanding
253.46M
No. of employees
6K
Open
R$80.08
High
R$80.08
Low
R$80.08
Mkt. cap
128.50B
Avg. vol.
374.00
Volume
1.00
52-wk high
R$89.01
52-wk low
R$65.18
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
ad-hoc-news.de
·
16 hours ago
Vertex Pharma stock sits at EUR 459.90 with USD 130.1 billion market cap
Investing.com
·
18 hours ago
BofA cuts Vertex stock price target to $667 on CF franchise outlook
ad-hoc-news.de
·
1 day ago
Vertex Pharma stock pre-market at EUR 456.63
Simply Wall Street
·
1 day ago
Vertex Pharmaceuticals (VRTX) Stock May Be 33% Undervalued Following New ALYFTREK Data
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc BDR
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com